These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26418703)

  • 1. Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury.
    Oellerich M; Walson PD; Beck J; Schmitz J; Kollmar O; Schütz E
    Ther Drug Monit; 2016 Apr; 38 Suppl 1():S75-9. PubMed ID: 26418703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
    Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
    PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.
    Oellerich M; Schütz E; Kanzow P; Schmitz J; Beck J; Kollmar O; Streit F; Walson PD
    Ther Drug Monit; 2014 Apr; 36(2):136-40. PubMed ID: 24452066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation.
    Beck J; Oellerich M; Schulz U; Schauerte V; Reinhard L; Fuchs U; Knabbe C; Zittermann A; Olbricht C; Gummert JF; Shipkova M; Birschmann I; Wieland E; Schütz E
    Transplant Proc; 2015 Oct; 47(8):2400-3. PubMed ID: 26518940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury.
    Beck J; Bierau S; Balzer S; Andag R; Kanzow P; Schmitz J; Gaedcke J; Moerer O; Slotta JE; Walson P; Kollmar O; Oellerich M; Schütz E
    Clin Chem; 2013 Dec; 59(12):1732-41. PubMed ID: 24061615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Universal Droplet Digital PCR Approach for Monitoring of Graft Health After Transplantation Using a Preselected SNP Set.
    Beck J; Oellerich M; Schütz E
    Methods Mol Biol; 2018; 1768():335-348. PubMed ID: 29717452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
    Brunet M; van Gelder T; Åsberg A; Haufroid V; Hesselink DA; Langman L; Lemaitre F; Marquet P; Seger C; Shipkova M; Vinks A; Wallemacq P; Wieland E; Woillard JB; Barten MJ; Budde K; Colom H; Dieterlen MT; Elens L; Johnson-Davis KL; Kunicki PK; MacPhee I; Masuda S; Mathew BS; Millán O; Mizuno T; Moes DAR; Monchaud C; Noceti O; Pawinski T; Picard N; van Schaik R; Sommerer C; Vethe NT; de Winter B; Christians U; Bergan S
    Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function.
    Adamek M; Opelz G; Klein K; Morath C; Tran TH
    Clin Chem Lab Med; 2016 Jul; 54(7):1147-55. PubMed ID: 26574891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection.
    Brunet M; Millán López O; López-Hoyos M
    Ther Drug Monit; 2016 Apr; 38 Suppl 1():S21-8. PubMed ID: 26444655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.
    Macher HC; García-Fernández N; Adsuar-Gómez A; Porras-López M; González-Calle A; Noval-Padillo J; Guerrero JM; Molinero P; Borrego-Domínguez JM; Herruzo-Avilés Á; Rubio A
    Clin Chim Acta; 2019 Aug; 495():590-597. PubMed ID: 31175849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation.
    Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
    Ther Drug Monit; 2023 Feb; 45(1):20-25. PubMed ID: 36127770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.
    Oellerich M; Christenson RH; Beck J; Schütz E; Sherwood K; Price CP; Keown PA; Walson PD
    J Appl Lab Med; 2020 Sep; 5(5):993-1004. PubMed ID: 32447378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical epigenetics and acute/chronic rejection in solid organ transplantation: An update.
    Vasco M; Benincasa G; Fiorito C; Faenza M; De Rosa P; Maiello C; Santangelo M; Vennarecci G; Napoli C
    Transplant Rev (Orlando); 2021 Apr; 35(2):100609. PubMed ID: 33706201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.
    Millán O; Urtasun N; Brunet M
    Transplant Rev (Orlando); 2009 Apr; 23(2):120-8. PubMed ID: 19298943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic studies in tolerance: Lessons learned and the path forward.
    Kurian SM; Whisenant TC; Mathew JM; Miller J; Leventhal JR
    Hum Immunol; 2018 May; 79(5):395-401. PubMed ID: 29481826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
    Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-derived cell-free DNA as a diagnostic tool in transplantation.
    Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
    Front Genet; 2022; 13():1031894. PubMed ID: 36339004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.